INTL MEDICATED
GenericsINTL MEDICATED is a generic drug manufacturer focused on Cardiovascular.
INTL MEDICATED's Key Drugs
INTL MEDICATED's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
INTL MEDICATED's Recent FDA Approvals
New NDA/BLA approvals for INTL MEDICATED over the last two years — novel drugs only, excluding generics and label supplements.
INTL MEDICATED's Therapeutic Areas
INTL MEDICATED's approved drugs and pipeline span 1 therapeutic area, led by Cardiovascular, across 0 biologic and 0 small-molecule drugs. Weighted by commercial stage — approved drugs count most, then late-stage trials.
INTL MEDICATED's Top Competitors
INTL MEDICATED's closest competitors by therapeutic-area and drug-target overlap include Novartis, Merck, and Baxter. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
INTL MEDICATED Pipeline Snapshot
Active clinical trials for INTL MEDICATED across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Cardiovascular pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2002-01-09
- Latest
- 2023-01-17
- Applications
- 3